ZIONA, Israel, July 21 /PRNewswire-FirstCall/ — PROLOR Biotech, Inc. , a company developing next generation biobetter therapeutic proteins, today announced initiation of a Phase II clinical trial of hGH-CTP, the company’s proprietary biobetter version of human growth hormone .
Categories
- Andropause
- Anti-Aging Medicine
- Biotechnology
- Endocrinology
- Exercise And Fitness
- Gene therapy
- HCG Therapy
- Hormone Replacement Therapy
- Infertility
- Integrative Medicine
- Longevity
- Longevity Medicine
- Menopause Management
- Nutraceuticals
- Nutrition
- Preventative Medicine
- Regenerative Medicine
- Sexual Dysfunction
- Stem Cell Therapy
- Testosterone
- Weight Management
Archives